Incannex Healthcare Inc. — Investor Relations & Filings
Filings indexed
248
across all filing types
Latest filing
2026-04-22
Regulatory Filings
Country
US
United States of America
Listing
US
IXHL
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company focused on the research and development of medicinal cannabinoid and psychedelic-based therapies. The company develops proprietary pharmaceutical products for conditions with significant unmet medical needs, including obstructive sleep apnea, traumatic brain injury, and inflammatory diseases. Its core activity involves advancing a diverse pipeline of drug candidates through rigorous clinical trials and regulatory pathways, primarily with the U.S. Food and Drug Administration (FDA). Incannex aims to deliver innovative, regulated medicines by targeting the underlying biological mechanisms of chronic conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-04-22 | English | |
| 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-27 | English | |
| 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-25 | English | |
| 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-18 | English | |
| 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-17 | English | |
| 8-K - INCANNEX HEALTHCARE INC. (0001873875) (Filer) | 2026-02-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 35239112 | 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-04-22 | English | ||
| 33059158 | 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-27 | English | ||
| 33039781 | 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-25 | English | ||
| 32974949 | 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-18 | English | ||
| 32963921 | 8-K - Incannex Healthcare Inc. (0001873875) (Filer) | 2026-03-17 | English | ||
| 32900207 | 8-K - INCANNEX HEALTHCARE INC. (0001873875) (Filer) | 2026-02-25 | English | ||
| 32145868 | 10-Q Filing | 2026-02-13 | English | ||
| 32145764 | 8-K Filing | 2026-01-29 | English | ||
| 13499216 | CURRENT REPORT | 2026-01-22 | English | ||
| 13499228 | CURRENT REPORT | 2026-01-16 | English | ||
| 13499260 | CURRENT REPORT | 2026-01-15 | English | ||
| 13499266 | CURRENT REPORT | 2026-01-14 | English | ||
|
2025
3 filings
| |||||
| 13499267 | CURRENT REPORT | 2025-12-18 | English | ||
| 13499268 | DEFINITIVE ADDITIONAL MATERIALS | 2025-12-18 | English | ||
| 13499271 | DEFINITIVE ADDITIONAL MATERIALS | 2025-12-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Incannex Healthcare Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34592/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34592 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34592 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34592 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34592}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Incannex Healthcare Inc. (id: 34592)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.